Deoxyribonucleic acid obtained from 2 large DCM families was studied using whole-exome sequencing and cosegregation analysis resulting in the identification of a novel disease gene, FLNC. On electron microscopy, the flncb morpholino knockdown zebrafish heart showed defects within the Z-discs and sarcomere disorganization.
The 2 families, from the same Italian region, harbored the same FLNC splicesite mutation (FLNC c.7251D1G>A).
A third U.S. family was then identified with a novel FLNC splice-site mutation (FLNC c.5669-1delG) that leads to haploinsufficiency as shown by the FLNC Western blot analysis of the heart muscle.
The FLNC ortholog flncb morpholino was injected into zebrafish embryos, and when flncb was knocked down caused a cardiac dysfunction phenotype.
On electron microscopy, the flncb morpholino knockdown zebrafish heart showed defects within the Z-discs and sarcomere disorganization. D ilated cardiomyopathy (DCM) is a severe disease of the heart muscle characterized by ventricular enlargement and systolic dysfunction leading to progressive heart failure and is among the most common causes of cardiovascular mortality (1, 2) . Approximately 30% to 40% of cardiomyopathy cases are familial and attributable to genetic causes (3) , and over 30 genes have been shown to cause DCM. However, approximately 50% of DCM cases have unknown causative mutations (4) . This apparent gap in our understanding of the disease has prompted ongoing studies to identify additional DCM candidate genes (5, 6) .
One such novel candidate gene is filamin C (FLNC), which encodes the structural protein FLNC, an actin-crosslinking protein within the sarcomere of striated muscle. FLNC is located on the chromosome region 7q32-q35 (7) . Until recently, deletion/insertion frameshift, point, and nonsense FLNC mutations have only been reported in association with isolated skeletal distal and myofibrillar myopathy diagnoses (8) (9) (10) (11) (12) . However, in 2014, Brodehl et al. blood pressure >160/110 mm Hg; obstruction >50% of a major coronary artery branch; alcohol intake >100 g/day; persistent high-rate supraventricular arrhythmia; systemic diseases; pericardial diseases; congenital heart diseases; cor pulmonale; and myocarditis. Informed consent was obtained from all living subjects and local institutional review boards approved the protocol.
WHOLE EXOME SEQUENCING AND BIOINFORMATICS ANALYSIS. Genomic deoxyribonucleic acid (DNA) was Begay et al.
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A U G U S T 2 0 1 6 : 3 4 4 -5 9 extracted, and WES was performed and analyzed using previous published methods (17 
Begay et al. At 72 hpf and 7 dpf, zebrafish cardiac phenotypes and survivors were analyzed using a chi-square test to detect significant differences.
RESULTS
WHOLE EXOME SEQUENCING. Members of family TSFDC029 were clinically characterized ( Table 1) , and 3 affected individuals underwent WES ( Figure 1A ).
Upon bioinformatic filtering of identified polymorphisms, and confirmation by Sanger sequencing, an 8-candidate variant list that cosegregated in the 3 affected individuals was generated (Supplemental Table 2 ). Further cosegregation analysis using samples from unaffected subjects was used to exclude variants that were present in 2 or more unaffected family members. All variants were excluded except FLNC c.7251þ1 G>A (NM_001458). This variant was
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found to be absent from the 1,000 Genomes Project, GO ESP database, and ExAC (Cambridge, Massachusetts) (34 Begay et al.
sequence similarity to the human FLNC gene than RF and heart rate were normally (Gaussian) distributed according to the Shapiro-Wilk test: analysis of variance indicated a significant difference among treatments Representative zebrafish heart pictures for embryo uninjected and flncb MO coinjected with p53 MO zebrafish embryos at 72 hpf. Among the flncbþp53 MO-injected zebrafish, they show cardiac phenotype, and GFP hearts further show less heart looping, elongated atrium, pericardial edema, and a truncated ventricle.
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contraction, flncbþp53 MO-depleted embryos were able to maintain normal SV ( Figure 5C ) and normal cardiac output ( Figure 5D ) through the first 2 days of development. 
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joined by distinct Z-discs ( Figure 6A ). In contrast, flncbþp53 MO embryos showed myofibrils composed of fewer consecutive sarcomeres, or myofibrils in abnormal arrangements with Z-discs ( Figures 6B to 6D) .
In most cases, Z-discs appeared irregular or were seemingly absent. However, cross sections revealed that the primary arrangement of thick and thin filaments into hexagonal lattices appears normal, Begay et al.
suggesting that initial sarcomerogenesis was normal, but that myofibril growth was impaired.
Flncb-depleted cardiomyocytes developed small vacuoles associated with, or near, the cell membrane. In some cases, the vacuoles were quite large ( Figure 6E) , suggesting that intercellular attachments had ruptured. Potential autophagic vesicles were observed in regions with highly disorganized sarcomeres ( Figure 6F) . Taken showed an arrhythmogenic trait, with high incidence of sudden cardiac death. Remarkably, arrhythmias were also reported in restrictive cardiomyopathy (atrial fibrillation, conduction disease) and HCM (sudden cardiac death) associated with FLNC variants (13, 14) .
FLNC is primarily expressed in striated muscle, where it clearly plays an important role on the basis of its association with myofibrillar myopathies (10, 12, 36, 37) . The FLNC protein is relatively specific to skeletal and cardiac muscle, where it is has been shown to be an actin-cross-linking protein and interacts with the dystrophin-associated-glycoprotein complex, integrin, and Z-disc proteins (FATZ-1, myotilin, myopodin), suggesting its role is to provide mechanical stability within the sarcomere (37, 38) . In this study, the flncb gene was selected as the initial candidate to test the hypothesis that FLNC protein is critical for cardiac development, on the basis of the 82% amino acid identity between zebrafish Flncb and human FLNC. The zebrafish genome also contains a flnca ortholog that is reported to have minimal cardiac expression (25) . We have preliminary data indicating that flnca is indeed expressed in 48 hpf zebrafish hearts, and further studies will therefore be needed to generate flnca mutants and determine whether doubly mutant embryos have a stronger cardiac defect than do flncb-depleted embryos.
Cardiac tissue was unavailable from 2 of our families (TSFDC029 and TSFDC031), limiting our ability to infer mechanisms beyond the data from the affected heart studied from family DNFDC057. We predict that our reported FLNC variants alter RNA splicing, likely leading to reduced protein expression and DCM via a haploinsufficiency model. The reduced FLNC protein we report from an affected explanted heart is consistent with this model, but additional data are needed before concluding that haploinsufficiency is the principal mechanism of DCM in these families.
CONCLUSIONS
Using WES in families with previously unknown causes of DCM, we have described 2 novel splice site mutations in the FLNC gene, which cosegregated with a severe cardiac phenotype characterized by a high rate of arrhythmia and sudden death. The DCM phenotype was cardiac-restricted with no skeletal myopathy. The variants detected lead to abnormal splicing and may mediate pathogenicity via haploinsufficiency, as supported by our functional zebrafish data and Western blot analysis, suggesting that approaches to augment endogenous FLNC protein could represent a treatment strategy in these cases. Our data, together with 2 DCM population screenings (53,54), the study of other cardiomyopathies (HCM and restrictive) (13, 14) , and previous data on MFM (4, 10, 12, 36, 37) 
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